Showing results (81-90 of 132) with videos related to
Sort By:
Pageof 14
Circulation|February 18, 2004
Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathyBarry J Maron, Venkatakrishna N Tholakanahalli, Andrey G Zenovich, et al.Lancet (London, England)|April 4, 2003
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational studyStefan D Anker, Abdissa Negassa, Andrew J S Coats, et al.American Journal of Hypertension|January 31, 2004
Clinical experience with perindopril in African-American hypertensive patients: a large United States community trialJay N Cohn, Stevo Julius, Joel Neutel, et al.American Heart Journal|January 6, 2005
Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT)Lawrence Baruch, Robert D Glazer, Nora Aknay, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 29, 2004
Clinical experience with perindopril in elderly hypertensive patients: a subgroup analysis of a large community trialJoel M Neutel, Michael A Weber, Stevo Julius, et al.Journal of Cardiac Failure|November 30, 2010
Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT)Serge Masson, Scott Solomon, Laura Angelici, et al.European Journal of Heart Failure|December 15, 2006
Body mass index, prognosis and mode of death in chronic heart failure: results from the Valsartan Heart Failure TrialMariantonietta Cicoira, Aldo Pietro Maggioni, Roberto Latini, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|October 18, 2005
Expanding the definition and classification of hypertensionThomas D Giles, Bradford C Berk, Henry R Black, et al.American Journal of Hypertension|December 6, 2008
Coadministered amlodipine and atorvastatin produces early improvements in arterial wall compliance in hypertensive patients with dyslipidemiaJay N Cohn, Daniel J Wilson, Joel Neutel, et al.Journal of Cardiac Failure|June 10, 2006
The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT)Serge Masson, Roberto Latini, Inder S Anand, et al.Pageof 14